These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33930380)

  • 1. The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
    Roe AH; McAllister A; Flynn AN; Martin B; Jiang E; Koelper N; Schreiber CA
    Contraception; 2021 Oct; 104(4):432-436. PubMed ID: 33930380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
    Flynn AN; Roe AH; Koelper N; McAllister A; Sammel MD; Schreiber CA
    Contraception; 2021 Jun; 103(6):404-407. PubMed ID: 33476659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
    Sonalkar S; Koelper N; Creinin MD; Atrio JM; Sammel MD; McAllister A; Schreiber CA
    Am J Obstet Gynecol; 2020 Oct; 223(4):551.e1-551.e7. PubMed ID: 32305259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
    Schreiber CA; Creinin MD; Atrio J; Sonalkar S; Ratcliffe SJ; Barnhart KT
    N Engl J Med; 2018 Jun; 378(23):2161-2170. PubMed ID: 29874535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early pregnancy loss medical management in clinical practice.
    Baker CC; Wu BT; Han G; Flynn AN; Creinin MD
    Contraception; 2023 Oct; 126():110134. PubMed ID: 37524147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding pattern after medical management of early pregnancy loss with mifepristone-misoprostol and its prognostic value: a prospective observational cohort study.
    Enzelsberger SH; Wetzlmair D; Hermann P; Wagner H; Shebl O; Oppelt P; Trautner PS
    Arch Gynecol Obstet; 2022 Aug; 306(2):349-355. PubMed ID: 34694431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial.
    Dragoman MV; Grossman D; Kapp N; Huong NM; Habib N; Dung DL; Tamang A
    Reprod Health; 2016 Oct; 13(1):132. PubMed ID: 27733165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone pretreatment followed by misoprostol 200 mcg buccal for the medical management of intrauterine fetal death at 14-28 weeks: A randomized, placebo-controlled, double blind trial.
    Bracken H; Ngoc NTN; Ha DQ; Paredes NR; Quyet VB; Linh NTH; Ortiz MA; Bousieguez M; Winikoff B
    Contraception; 2020 Jul; 102(1):7-12. PubMed ID: 32135126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Mifepristone Pretreatment for the Medical Management of Nonviable Early Pregnancy: Secondary Analysis of a Randomized Clinical Trial.
    Nagendra D; Koelper N; Loza-Avalos SE; Sonalkar S; Chen M; Atrio J; Schreiber CA; Harvie HS
    JAMA Netw Open; 2020 Mar; 3(3):e201594. PubMed ID: 32215633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing letrozole and mifepristone pre-treatment in medical management of first trimester missed miscarriage: a prospective open-label non-inferiority randomised controlled trial.
    Du L; Li HWR; Gemzell-Danielsson K; Zhang Z; Du Y; Zhang W; Xu B; Wang X; Wang Y; Wan W; Chang Y; Diao W; Wang Y; Zhang L; Ho PC
    BJOG; 2024 Feb; 131(3):319-326. PubMed ID: 37667661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy.
    von Hertzen H; Honkanen H; Piaggio G; Bartfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Ngoc NT; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2003 Sep; 110(9):808-18. PubMed ID: 14511962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial.
    Dragoman MV; Grossman D; Nguyen MH; Habib N; Kapp N; Tamang A; Bessenaar T; Duong LD; Gautam J; Yoko JL; Hong M; Gulmezoglu M
    Contraception; 2021 Mar; 103(3):163-170. PubMed ID: 33451721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.
    Dzuba IG; Castillo PW; Bousiéguez M; Lugo Hernández EM; Castañeda Vivar JJ; Sanhueza Smith P
    Contraception; 2020 Aug; 102(2):104-108. PubMed ID: 32474060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study on the use of a two-week course of oral misoprostol in patients after termination of pregnancy with mifepristone and misoprostol.
    Tang OS; Gao PP; Cheng L; Lee S; Ho PC
    Contraception; 1998 Feb; 57(2):89-91. PubMed ID: 9589834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
    Schaff EA; Fielding SL; Westhoff C
    Contraception; 2001 Aug; 64(2):81-5. PubMed ID: 11704083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro].
    Stojnić J; Ljubić A; Jeremić K; Radunović N; Tulić I; Bosković V; Dukanac J
    Vojnosanit Pregl; 2006 Jun; 63(6):558-63. PubMed ID: 16796021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
    Reeves MF; Monmaney JA; Creinin MD
    Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
    Mittal S; Agarwal S; Kumar S; Batra A
    Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.